Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,565 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in Staging and Management of Non-Small Cell Lung Cancer (NSCLC) Patients Following the Implementation of Low-Dose Chest Computed Tomography (LDCT) Screening at Kaohsiung Medical University Hospital.
Chen CL, Hsu JS, Shen YW, Hsu CH, Kao SY, Lai WA, Chuang CH, Liu YW, Lee JY, Chou SH, Hung JY, Chong IW, Yang CJ. Chen CL, et al. Cancers (Basel). 2024 Nov 5;16(22):3727. doi: 10.3390/cancers16223727. Cancers (Basel). 2024. PMID: 39594683 Free PMC article.
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer.
Chuang CH, Chen HL, Chang HM, Tsai YC, Wu KL, Chen IH, Chen KC, Lee JY, Chang YC, Chen CL, Tu YK, Hung JY, Yang CJ, Chong IW. Chuang CH, et al. Among authors: chen ih, chen hl, chen kc, chen cl. Cancers (Basel). 2021 Apr 19;13(8):1966. doi: 10.3390/cancers13081966. Cancers (Basel). 2021. PMID: 33921762 Free PMC article. Review.
Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR Mutations: Systematic Review and Meta-Analysis.
Lee TH, Chen HL, Chang HM, Wu CM, Wu KL, Kuo CY, Wei PJ, Chen CL, Liu HL, Hung JY, Yang CJ, Chong IW. Lee TH, et al. Among authors: chen hl, chen cl. J Clin Med. 2022 Jun 12;11(12):3366. doi: 10.3390/jcm11123366. J Clin Med. 2022. PMID: 35743437 Free PMC article. Review.
Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR-mutated advanced non-small-cell lung.
Kuo CY, Tsai MJ, Hung JY, Lee MH, Wu KL, Tsai YC, Chuang CH, Huang CW, Chen CL, Yang CJ, Chong IW. Kuo CY, et al. Among authors: chen cl. Kaohsiung J Med Sci. 2024 May;40(5):467-476. doi: 10.1002/kjm2.12822. Epub 2024 Mar 25. Kaohsiung J Med Sci. 2024. PMID: 38523603 Free article.
Development of an Innovative Decision-Aid to Better Align Patients' Implantable Cardioverter Defibrillator Shock Status With Goals of Care.
Chen CL, Godfrey S, Newcomer K, Alvarez K, Garrett B, Zhang J, Patel N, Viamontes C, Shah N, Patel NS, Kelly MM, Sulistio MS. Chen CL, et al. Circ Cardiovasc Qual Outcomes. 2025 Jan 16:e011544. doi: 10.1161/CIRCOUTCOMES.124.011544. Online ahead of print. Circ Cardiovasc Qual Outcomes. 2025. PMID: 39817335 No abstract available.
4,565 results